Bionano Genomics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $3.0M | $9.2M | $17.9M | $5.1M | $24.6M | $38.4M | $17.3M | $16.5M |
| Accounts Receivable | $5.2M | $4.8M | $9.3M | $7.0M | $4.9M | $2.8M | $6.3M | $4.5M |
| Inventory | $7.8M | $13.3M | $27.6M | $29.8M | $12.4M | $3.3M | $3.4M | $1.1M |
| Total Current Assets | $45.4M | $39.5M | $140.1M | $157.3M | $272.4M | $46.8M | $28.3M | $23.0M |
| Property, Plant & Equipment | $14.8M | $19.2M | $23.3M | $18.0M | $10.3M | $4.9M | $1.9M | $1.8M |
| Goodwill | — | — | $0 | $77.3M | $56.2M | $7.2M | $0 | — |
| Intangible Assets (Excl. Goodwill) | $4.3M | $9.7M | $34.0M | $41.1M | $26.8M | $1.5M | $0 | — |
| Total Assets | $73.6M | $76.7M | $214.4M | $307.5M | $377.1M | $60.5M | $30.2M | $24.8M |
| Liabilities | ||||||||
| Accounts Payable | $5.6M | $7.0M | $10.4M | $12.5M | $10.8M | $2.9M | $2.7M | $1.4M |
| Total Current Liabilities | $22.9M | $37.3M | $100.0M | $35.9M | $21.8M | $8.9M | $26.4M | $4.5M |
| Long-Term Debt | — | — | — | — | $0 | $16.3M | $0 | $9.0M |
| Total Liabilities | $29.2M | $41.3M | $118.2M | $58.1M | $40.0M | $25.4M | $26.6M | $14.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-719.6M | $-693.2M | $-581.2M | $-348.7M | $-216.1M | $-143.7M | $-102.6M | $-72.8M |
| Total Stockholders' Equity | $44.4M | $35.4M | $96.2M | $249.4M | $337.1M | $35.1M | $3.6M | $10.1M |